← Back to Search

Nurse Navigator Program for High-Risk Hospital Patients

N/A

Waitlist Available

Led By George Pujalte, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Require total or partial hip or knee replacement and have one or more of the following diagnosis: Heart Failure (HF); Chronic obstructive pulmonary disease (COPD); Dialysis; Alcohol Abuse; Low BMI.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one year

Awards & highlights

Study Summary

This trial will test if an educational program can reduce hospital readmissions and patient satisfaction in high risk patients.

Who is the study for?

This trial is for patients needing hip or knee replacement surgery who also have heart failure, COPD, require dialysis, abuse alcohol, or have a low BMI. It's not open to those with reduced ability to consent due to cognitive issues.Check my eligibility

What is being tested?

The study tests if a Nurse Navigator Program can reduce hospital readmissions and improve patient satisfaction compared to usual care in high-risk surgical patients.See study design

What are the potential side effects?

Since this is an educational program rather than a medication, traditional side effects are not expected. However, participants may experience varying levels of satisfaction with the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I need a hip or knee replacement and have heart issues, lung problems, need dialysis, have alcohol abuse history, or low BMI.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Readmission rates

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Nurse NavigatorExperimental Treatment1 Intervention

Patients with chronic conditions slated for surgery contacted once by pre-operative nurse to discuss surgery, then contacted at intervals by nurse navigator study team members

Group II: Usual PracticeActive Control1 Intervention

Patients with chronic conditions slated for surgery contacted once by pre-operative nurse to discuss surgery

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,206 Previous Clinical Trials

3,766,783 Total Patients Enrolled

George Pujalte, MDPrincipal InvestigatorMayo Clinic

Media Library

Nurse Navigator Clinical Trial Eligibility Overview. Trial Name: NCT05592847 — N/A

Body Mass Index Research Study Groups: Usual Practice, Nurse Navigator

Body Mass Index Clinical Trial 2023: Nurse Navigator Highlights & Side Effects. Trial Name: NCT05592847 — N/A

Nurse Navigator 2023 Treatment Timeline for Medical Study. Trial Name: NCT05592847 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study recruiting participants at the present time?

"The clinical trial, which was posted on February 1st 2023 and last updated October 20th 2022 is not currently in the process of patient recruitment. However, there are other studies that have recently opened enrollment with 1393 trials actively recruiting patients."

Answered by AI